No profile data available.
PolyPid Ltd. (PYPD) is a healthcare company in the antibacterial pharmaceuticals industry, based in Petah Tikva, Israel, with about 69 full-time employees.
It reported revenue of $0 for fiscal year 2025, and net income of -$34.17 million. In Q1 2026 (the quarter ended March 31, 2026) revenue was $0. Its market capitalization was $102.98 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
, a biopharmaceutical company, developing targeted, locally administered, and prolonged-release therapeutics using its proprietary polymer-lipid encapsulation matrix (PLEX) technology to address unmet medical needs.
PolyPid reported $0 in revenue for fiscal year 2025. In Q1 2026 revenue was $0.
$102.98 million as of October 9, 2026.
Listed companies of a similar size in the same industry (antibacterial pharmaceuticals) include AN2 Therapeutics, Inc. (ANTX), BGM Group Ltd. (BGM), Armata Pharmaceuticals, Inc. (ARMP), Spero Therapeutics, Inc. (SPRO).